🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
562,02 USD
Máx. histórico
608,49
2 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,64%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-0,65%
Cierre anterior
565,72
Rango de hoy
559,41 – 569,45
Volumen hoy
454.934
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,22 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 3 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 03/09/2009 | 45,89 | 46,39 | 45,35 | 45,80 | -0,80% | 2,27% | 447.800 |
| 02/09/2009 | 45,75 | 46,87 | 45,75 | 46,17 | +1,26% | 2,45% | 696.000 |
| 01/09/2009 | 45,75 | 46,61 | 45,36 | 45,60 | -0,35% | 2,73% | 528.200 |
| 31/08/2009 | 45,72 | 46,39 | 45,37 | 45,76 | -0,66% | 2,23% | 718.000 |
| 28/08/2009 | 45,75 | 46,21 | 45,45 | 46,06 | +1,01% | 1,66% | 389.400 |
| 27/08/2009 | 46,41 | 46,41 | 45,05 | 45,60 | +0,13% | 2,92% | 542.200 |
| 26/08/2009 | 45,75 | 46,47 | 45,45 | 45,54 | -0,23% | 2,22% | 481.800 |
| 25/08/2009 | 46,10 | 46,35 | 45,50 | 45,65 | +0,32% | 1,83% | 714.600 |
| 24/08/2009 | 47,12 | 47,12 | 45,43 | 45,50 | -2,71% | 3,59% | 813.000 |
| 21/08/2009 | 46,60 | 47,05 | 46,38 | 46,77 | +0,85% | 1,44% | 662.800 |
| 20/08/2009 | 46,58 | 46,86 | 45,98 | 46,37 | +0,15% | 1,90% | 747.800 |
| 19/08/2009 | 45,25 | 46,81 | 45,25 | 46,30 | +1,51% | 3,44% | 1.015.200 |
| 18/08/2009 | 45,31 | 45,81 | 45,00 | 45,61 | +1,10% | 1,79% | 559.200 |
| 17/08/2009 | 45,21 | 45,52 | 44,98 | 45,12 | -1,26% | 1,21% | 1.583.400 |
| 14/08/2009 | 45,51 | 46,00 | 45,07 | 45,69 | -0,40% | 2,04% | 350.800 |
| 13/08/2009 | 45,53 | 45,88 | 45,00 | 45,88 | +0,75% | 1,92% | 300.400 |
| 12/08/2009 | 45,48 | 46,06 | 45,01 | 45,54 | +0,14% | 2,31% | 776.200 |
| 11/08/2009 | 45,45 | 46,25 | 45,37 | 45,47 | -1,01% | 1,94% | 322.600 |
| 10/08/2009 | 45,51 | 46,21 | 45,33 | 45,94 | -0,09% | 1,93% | 495.000 |
| 07/08/2009 | 46,10 | 46,40 | 45,53 | 45,98 | +0,12% | 1,88% | 665.800 |
| 06/08/2009 | 47,12 | 47,12 | 45,77 | 45,92 | -3,15% | 2,85% | 1.418.000 |
| 05/08/2009 | 47,50 | 48,08 | 46,78 | 47,42 | -1,43% | 2,74% | 1.384.800 |
| 04/08/2009 | 46,93 | 48,11 | 46,74 | 48,11 | +1,87% | 2,93% | 852.400 |
| 03/08/2009 | 45,51 | 47,28 | 45,51 | 47,22 | +1,97% | 3,89% | 1.896.600 |
| 31/07/2009 | 47,52 | 48,50 | 45,00 | 46,31 | -3,11% | 7,36% | 4.028.800 |
| 30/07/2009 | 43,42 | 48,35 | 42,77 | 47,80 | +11,78% | 12,85% | 9.170.000 |
| 29/07/2009 | 43,13 | 43,86 | 42,71 | 42,76 | -0,79% | 2,67% | 1.317.600 |
| 28/07/2009 | 43,25 | 43,93 | 43,00 | 43,10 | -0,74% | 2,15% | 910.800 |
| 27/07/2009 | 43,70 | 44,36 | 43,30 | 43,42 | -0,44% | 2,43% | 617.800 |
| 24/07/2009 | 42,76 | 43,90 | 42,76 | 43,61 | +1,89% | 2,67% | 1.044.400 |